Tuesday, January 27, 2015
Allopathic Treatment for diabetic patients
When your type 2 diabetic patient is uncontrolled with metformin monotherapy, Switch to
Combination is a novel drug that provides both STRENGTH & SAFETY.This combination is that the first ever FDA approved DPP-4 ( dipeptidyl peptidase 4) in the world.
# Reduced insulin secretion
# Increase insulin resistance
# Hepatic glucose overproduction.
# Effective reduction in HbA1c
# Effective reduction in FPG & PPG
# Very low rate of hypoglycemia with no severity
# Increase beta-cell function
# No risk of weight gain.